Exciting results from a trial using the Chinese medicine compound Tongxinluo with unknown active ingredients are shown.

Published Date: 01 Nov 2023

A Chinese traditional medicine substance called Tongxinluo has been shown in a clinical trial directed by Yuejin Yang of the Chinese Academy of Medical Sciences and Peking Union Medical College, China, to lessen significant adverse cardiac events.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.

2.

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

3.

FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.

4.

Durvalumab Wins FDA Approval in Limited-Stage SCLC

5.

Telehealth in the pandemic era resulted in fewer therapy interruptions.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot